177 related articles for article (PubMed ID: 37989822)
21. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
Cai Z; Zhou F
Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature.
Chen Y; Guo L; Zhou Z; An R; Wang J
BMC Genomics; 2022 Mar; 23(1):245. PubMed ID: 35354376
[TBL] [Abstract][Full Text] [Related]
23. System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.
Wu Z; Yu J; Han T; Tu Y; Su F; Li S; Huang Y
BMC Musculoskelet Disord; 2024 Jun; 25(1):437. PubMed ID: 38835052
[TBL] [Abstract][Full Text] [Related]
24. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
Front Genet; 2022; 13():1039465. PubMed ID: 36338978
[No Abstract] [Full Text] [Related]
25. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
[TBL] [Abstract][Full Text] [Related]
26. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration.
Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027
[TBL] [Abstract][Full Text] [Related]
27. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
28. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
Zhang G; Chen A; Fang J; Wu A; Chen G; Tai P; Chen H; Chen X; Cao K
Front Immunol; 2023; 14():1105210. PubMed ID: 37114037
[TBL] [Abstract][Full Text] [Related]
29. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer.
Li Y; Pan Q; Cheng M; Wu Z
Aging (Albany NY); 2023 Mar; 15(7):2541-2553. PubMed ID: 36996495
[TBL] [Abstract][Full Text] [Related]
31. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
Zhao H; Chen Y; Shen P; Gong L
Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
[TBL] [Abstract][Full Text] [Related]
33. Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis.
Zhu Y; Han D; Duan H; Rao Q; Qian Y; Chen Q; Du X; Ni H; Wang S
Stem Cells Int; 2023; 2023():3827999. PubMed ID: 36818162
[TBL] [Abstract][Full Text] [Related]
34. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
35. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
36. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning.
Liu J; Liu L; Antwi PA; Luo Y; Liang F
Front Genet; 2022; 13():858466. PubMed ID: 35719392
[No Abstract] [Full Text] [Related]
39. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
40. Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer.
Lei J; Guo G; Liang D; Gong L; Zhang L; Wang X
Biochem Biophys Res Commun; 2023 Sep; 673():137-144. PubMed ID: 37385008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
